Literature DB >> 12897444

Antioxidants in cancer therapy: is there a rationale to recommend antioxidants during cancer therapy?

Hans Konrad Biesalski1, Jürgen Frank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12897444     DOI： 10.1002/biof.5520170122

Source DB:  PubMed          Journal:  Biofactors        ISSN： 0951-6433            Impact factor:   6.113


× No keyword cloud information.
  4 in total

1.  Is the combinational administration of doxorubicin and glutathione a reasonable proposal?

Authors:  Bo-Yu Shen; Chong Chen; Yang-Fan Xu; Jia-Jia Shen; Hui-Min Guo; Hao-Feng Li; Xi-Nuo Li; Dian Kang; Yu-Hao Shao; Zhang-Pei Zhu; Xiao-Xi Yin; Lin Xie; Guang-Ji Wang; Yan Liang
Journal:  Acta Pharmacol Sin       Date:  2018-09-14       Impact factor: 6.150

Review 2.  Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy.

Authors:  Akiko Nakayama; Karen P Alladin; Obianuju Igbokwe; Jeffrey D White
Journal:  Cancer Invest       Date:  2011-12       Impact factor: 2.176

3.  Tissue-protective activity of selenomethionine and D-panthetine in B16 melanoma-bearing mice under doxorubicin treatment is not connected with their ROS scavenging potential.

Authors:  Rostyslav R Panchuk; Nadia R Skorokhyd; Yuliya S Kozak; Liliya V Lehka; Andrey G Moiseenok; Rostyslav S Stoika
Journal:  Croat Med J       Date:  2017-04-14       Impact factor: 1.351

Review 4.  Nanocarrier-mediated antioxidant delivery for liver diseases.

Authors:  Senlin Li; Huiru Li; Xiaoding Xu; Phei Er Saw; Lei Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.